Background: Fat grafting is a common procedure in plastic surgery but associated with unpredictable graft retention. Adipose tissue (AT) "product" quality is affected by the methods used for harvest, processing and transfer, which vary widely amongst surgeons. Currently, there is no method available to accurately assess the quality of AT. Objectives: In this study, we present a novel method for the assessment of AT product quality through direct measurements of oxygen consumption rate (OCR). OCR has exhibited potential in predicting outcomes following pancreatic islet transplant. Our study aim was to reapportion existing technology for its use with AT preparations and to confirm that these measurements are feasible. Methods: OCR was successfully measured for en bloc and postprocessed AT using a stirred microchamber system. OCR was then normalized to DNA content (OCR/DNA), which represents the AT product quality. Results: Mean (±SE) OCR/DNA values for fresh en bloc and post-processed AT were 149.8 (± 9.1) and 61.1 (± 6.1) nmol/min/mg DNA, respectively. These preliminary data suggest that: (1) OCR and OCR/DNA measurements of AT harvested using conventional protocol are feasible; and (2) standard AT processing results in a decrease in overall AT product quality. Conclusions: OCR measurements of AT using existing technology can be done and enables accurate, real-time, quantitative assessment of the quality of AT product prior to transfer. The availability and further validation of this type of assay could enable optimization of fat grafting protocol by providing a tool for the more detailed study of procedural variables that affect AT product quality.
limitations and none provide accurate, quantitative, operator-independent, real-time data. 3 This lack of reliable quality assessment data is in part reflected in the limited protocol optimization that has been done over the nearly six decades of fat grafting research.
A similar problem has been encountered in the field of pancreatic islet transplant. As with fat grafting, islet transplant involves harvest, processing, and transfer of multicellular aggregates. Each of the steps involved in the preparation of the islet cell product has the potential to adversely affect the quality of the final cell product being transplanted and thus the outcomes of the transplant. Similarly, there has been a paucity of available assays for the reliable quality assessment of islet tissue product prior to transplant. 4 Out of this need arose the development of several promising quality assessment assays, including the stirred microchamber system for the direct measurement of cell and/or tissue oxygen consumption rate (OCR). 5 OCR measurements can provide objective reliable data, are not dependent on the operator, and can be collected in just a few minutes. OCR measurements of islet cell product prior to transplant have been able to predict posttransplant outcomes (diabetes reversal) in both animal models [5] [6] [7] [8] [9] and following clinical transplantation. 10, 11 The stirred microchamber system is currently being used at several major transplant centers prior to releasing clinical-grade islet product for transplant.
Since pancreatic islets and AT parcels are similar in that both are multicellular products that are eventually transplanted, it may be that the OCR measurements developed for islet characterization could be used in fat grafting research. In this preliminary study, it was our aim to reapportion and begin to validate existing technology for the direct measurement of AT product OCR following harvest and processing using conventional methods.
METHODS

Adipose Tissue Harvest
All human tissue was procured at the University of Minnesota hospital between September 2013 and April 2015 following Institutional Review Board approval (IRB Code Number: 1309M42682). AT was harvested from the abdomen and flanks, and processed in the same manner each time to limit variability. Data presented herein were generated using AT harvested from one patient, a 36-year-old female with a body mass index of 34 kg/m 2 and without other medical comorbidities, undergoing fat grafting for revision breast reconstructive surgery. Fresh en bloc AT samples were procured by making a skin incision, directly excising approximately 1 mL of AT and transferred into a conical tube which was then placed on ice. Postprocessed AT samples were procured following standard processing as done by the senior operating surgeon (B.L.C.); This involved suction-assisted liposuction at a negative suction pressure of −250 mm Hg using a Mercedes type 5-mm (outer diameter) × 32 cm (length) cannula (Becon Medical Limited, Tucson, AZ). After SAL, AT samples were additionally rinsed using the Revolve system (LifeCell, Bridgewater, NJ) following their standard instructions for use. Following harvest and rinse, postprocessed AT samples were transferred into a conical tube which was then placed on ice. For samples from which data are presented herein, the cold ischemia time (CIT) was limited to 3.5 hours and due to the rapid nature of the OCR testing the difference in CIT between tested samples was usually <60 minutes. Nonetheless, testing was done in a randomized fashion to not systematically subject any particular sample to additional CIT.
Oxygen Consumption Rate Measurements
OCR measurements were done using the stirred microchamber system (Instech Laboratories, Plymouth Meeting, PA) using protocol modified from its original use in the characterization of pancreatic islet tissue product. 5, 8 Briefly, each stirred microchamber is composed of stainless steel and contains a fiber optic oxygen sensor which is calibrated to oxygen partial pressures (pO 2 ) of 0 and 160 mm Hg prior to experimentation. Aliquots of AT product were suspended in standard culture medium (ME199, Sigma-Aldrich, St. Louis, MO) containing no serum (to prevent additional bubble formation within the chamber) and transferred into microchambers. Each sample was continuously and gently stirred using a magnetic stir bar to prevent oxygen gradients from forming throughout the chamber and specimens were equilibrated at 37°C for at least 15 minutes. Microchambers were then sealed using a glass cap to prevent gas exchange with the ambient air ( Figure 1 ). Average pO 2 measurements in each stirred microchamber were measured in real-time and the OCR (in units of nmol/min) of the AT product were calculated using the following formula:
(1)
where V is the volume of the microchamber, α is the Bunsen solubility coefficient of oxygen in aqueous solution at 37°C, and (ΔpO 2 /Δt) is the linear rate of change of pO 2 in the microchamber with respect to elapsed experimental time. OCR measurements were done within 3.5 hours of specimen collection to limit the CIT. Each experimental condition was tested with measurements done in quadruplicate.
DNA Content Quantification and Calculation of OCR/DNA
Following completion of an OCR measurement, the AT product aliquot in each microchamber was carefully collected and transferred into microcentrifuge tubes for DNA content quantification using a commercially available spectrophotometric assay (Quant-IT PicoGreen dsDNA kit, Invitrogen, Grand Island, NY) and a SpectraMax M5 plate reader (Molecular devices, Sunnyvale, CA). [6] [7] [8] [9] [10] [11] [12] [13] OCR was then normalized to the DNA content of the sample from which the OCR was measured to yield the ratio of OCR/DNA, which represents the fractional viability of the AT product since OCR is proportional to the amount of viable tissue and the DNA content is proportional to the total amount of tissue (both viable and nonviable). 4, 8, 9, 13 Statistical Analysis
All statistical analysis was done in Excel (Microsoft Corp., Redmond, WA) and/or GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA). Data was compared with paired two-tailed t test using 95% confidence intervals.
RESULTS
The stirred microchamber system was successfully used to generate OCR curves from en bloc as well as postprocessed human AT product, procured using conventional harvest and processing techniques prior to fat grafting. Oxygen partial pressure (pO 2 ) tracings are generated using the system and then linear regression analysis is done to calculate the slopes from the mid-portion of the tracing (Figure 2 ). . Schematic illustrating a cross-section of the stirred microchamber system used in the measurement of adipose tissue (AT) product oxygen consumption rate (OCR). The AT product aliquot in aqueous suspension is placed into the stainless steel microchamber. A beveled glass cap is then used to seal the microchamber from the ambient environment. Of note, air bubbles are expelled from the chamber through a small vent hole at the time the beveled glass cap is placed. The steel microchamber is enveloped in a water jacket that keeps the system stable at 37°C. A magnetic stir bar is located at the bottom of the microchamber and circulates the suspension to prevent spatial oxygen gradients from developing near the fluorooptic oxygen sensor located at the base. Raw data from actual oxygen partial pressure (pO 2 ) tracings measured in the stirred microchamber. Each tracing is a measurement taken following introduction of adipose tissue (AT) samples processed using conventional fat grafting protocol. The center part of the tracing is selected and the slope is calculated using linear regression to quantify the AT product oxygen consumption rate (OCR), a quantity that correlates with the total amount of viable AT in each microchamber. Each of the four differently colored lines are separate tracings from AT product aliquots in different microchambers. Once the OCR is calculated, the AT samples are removed from the microchambers and quantified for DNA content.
All calculated slopes had R 2 values of at least >0.85. Data collection is reproducible and can be done in minutes yielding quantitative data. Mean (± standard error [SE]) OCR/DNA of fresh en bloc AT product was 149.8 (± 9.1) nmol/min/mg DNA while post-processed AT product was 61.1 (± 6.1) nmol/ min/mg DNA (P = 0.002), which represents a significant reduction (~60%) in the fractional viability of AT following conventional harvest and processing prior to fat grafting ( Figure 3 ).
DISCUSSION
Our study confirms that OCR and OCR/DNA measurements can be done on AT product harvested and processed by conventional methods. This assay may enable optimization of fat grafting protocol in lieu of providing a means to assess the effect that procedural variables may have on the quality of an AT preparation. 14 Zielins et al discusses some work already done in the area of trying to optimize fat grafting protocol. 14 Procedural variables that could be studied may include (but are not limited to): donor site, wetting solution used, harvest technique, cannula type and size, additional processing done, and transfer technique. These variables may impact the quality of the AT product and the effects may be quantifiable using a tool such as the stirred microchamber. To date, the techniques available to characterize AT quality after its manipulation during fat harvest, processing, and transfer have significant limitations, 3 including that they are not truly quantitative.
OCR and OCR/DNA measurements may help stratify the magnitude of negative effects that procedural steps have on fat graft quality and may help frame a strategy for addressing protocol optimization. Based on this kind of data, it may be that acceptable parameters can be reliably defined for many key procedural variables. Once protocols are optimized, attention can be given to better designing the fat graft dimensions at the recipient site of transplant to enable the best chance of it surviving from the standpoint of oxygenation. 15 Additionally, enriching lipoaspirate with adipose-derived stem cells can be studied from the standpoint of how it impacts the OCR of the AT product. 14 An "ideal" AT product quality assessment tool has been described before 3 and as conceived would exhibit the following characteristics: Of these ideal characteristics, the OCR and OCR/DNA measurements performed in this study exhibit at least characteristics 1 to 5. Depending on the available budget of the laboratory or institution, the stirred microchamber system could be considered affordable and additional development may further reduce costs. Future studies are needed to better validate whether these quality assessment measurements are predictive of posttransfer fat graft retention in the clinical setting, which is beyond the scope and a limitation of this study. Another limitation of this study is our inability to compared fractional viability measurements as done with OCR/DNA with another method, but the authors believe that no other reliable method exists for characterizing AT viability. 3 Nevertheless, extensive additional work will involve further validation of the accuracy of the ability of OCR/DNA to reflect the true viability of an AT preparation.
OCR and OCR/DNA has been validated for its use in the characterization of pancreatic islet cell product. 4, 6, [8] [9] [10] [11] These measurements have been found to correlate with the cell product quality, 5 and are predictive of posttransplant outcomes (diabetes reversal) in animal models 6, 8, 9, 12 and clinical transplant. 10, 11 Additionally, OCR measurements are being done at some of the major transplant centers in continued validation of its clinical utility. Due to the similarities between islets and AT parcels (both multicellular aggregates of about similar size), there is no reason why the stirred microchamber cannot be used in the characterization of AT product quality. 3 OCR and OCR/DNA measurements done in this study have some limitations. These measurements do not provide Figure 3 . Mean (± SE) OCR/DNA measurements for fresh en bloc and postprocessed AT product. Difference in the measurements suggest a significant decline in the fractional viability or quality of the AT product following conventional harvest and processing of the fat graft prior to transfer. Measurements were done in quadruplicate as described previously in the Methods section.
any information about the composition of the AT product and only provide information regarding the viability. OCR is proportional to the amount of viable tissue, regardless of the type of tissue. OCR/DNA reflects the fractional viability by normalizing the total amount of viable tissue over the total amount of tissue (whether viable or nonviable) since DNA is stable for at least 24 to 48 hours after cell death. 16 However, neither OCR nor OCR/DNA distinguish amongst the different types of cells comprising the AT product, which include adipocytes, fibroblasts, vascular endothelium, and adipose-derived stem cells to name a few and which may differently affect the fat graft retention posttransplant. Since larger AT parcels remain oxygen diffusion-limited, much of their bulk may be anoxic and thus non-oxygen-consuming. In theory, this is reflected in the measurement by a lower OCR and OCR/DNA. Nonetheless, since the AT product is highly heterogeneous, if the small aliquots used in the measurements contain even a few larger AT parcels this may inaccurately underestimate the quality of the entire AT preparation. Though the tissue preparation is minimal, AT samples may need to be manipulated or minced to get them into the chambers to conduct the measurements. This additional manipulation may traumatize the AT sample beyond what is done to the preparation with standard harvest and processing protocol, which may also affect the true quality of the AT preparation. Unlike pancreatic islet product, AT preparations are composed of more fat and this may affect the measurement in several ways. First, a large fraction of oil solubilizes more oxygen and serves as a reservoir of available oxygen which may result in a lower effective OCR measurement. Second, oil−water interfaces create bubbles that trap air which may similarly affect the OCR measurement. Finally, in our study, no animal or clinical fat grafting was done to validate the utility of the OCR and OCR/DNA measurements in predicting fat graft retention, which will need to be done at some point.
Despite these limitations, OCR and OCR/DNA represents a promising tool for the assessment of AT product quality following standard harvest, processing and even transfer. Many of its limitations can be mitigated with additional development work. Future work will aim to further validate the correlation between OCR/DNA measurements and AT product fractional viability. OCR and OCR/ DNA measurements can then be used to characterize the impact changes made to key procedural variables have on the AT product quality. For example, measurements can be done on AT product harvested using smaller and larger diameter cannula to determine whether this variable has a quantifiable effect on the AT product quality. Once key procedural variables are examined for their full effects on AT product quality, fat grafting protocol can be optimized in a systematic bioengineered way. Ultimately, changes to fat grafting protocol can be then be validated by whether they improve retention following transfer.
CONCLUSIONS
OCR and OCR/DNA measurements using existing technology can be done on AT product and enables accurate, real-time, quantitative assessment of its quality prior to transfer. The availability and further validation of this type of assay could enable optimization of fat grafting protocol by providing a tool for the more detailed study of procedural variables that affect AT product quality.
